Danaher appoints Christopher Riley to Executive Vice President for Biotechnology

WASHINGTON, Oct. 31, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”), a leading global life sciences and diagnostics innovator, today announced that Christopher Riley has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Biotechnology business, effective January 1, 2024. Mr. Riley, currently Vice President and... Read more

Xylem Reports Third Quarter 2023 Results

Revenue of $2.1 billion , up 50% on a reported basis, and 10% organically Earnings per share of $0.63 , up 800%; adjusted earnings per share of $0.99 , up 14% Raising full-year revenue guidance to approximately $7.3B , up 32% from 30%, with expected organic revenue growth of 11%, up from 9% to 10% Read more

Bruker Announces Date and Time of Third Quarter 2023 Earnings Release and Webcast

Bruker Announces Date and Time of Third Quarter 2023 Earnings Release and Webcast BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2023 financial results before market opening on Thursday, November 2, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the... Read more